Search

Displaying results 291 - 300 of 7041 in total
  1. Indication

    Resistant to tyrosine kinase inhibitors

    go.drugbank.com/conditions/DBCOND0102379
    Drugs: Nilotinib
    Synonyms: Resistant to tyrosine kinase inhibitors, Resistant to Tyrosine Kinase Inhibitor Therapy
  2. Indication

    Responsive to previous drug therapy

    go.drugbank.com/conditions/DBCOND0135656
    Drugs: Amlodipine · Doravirine · Ivabradine
    Synonyms: Responsive to previous drug therapy
  3. Indication

    Testicular failure due to cryptorchidism

    go.drugbank.com/conditions/DBCOND0112666
    Drugs: Testosterone cypionate
    Synonyms: Testicular failure due to cryptorchidism
  4. Indication

    Unable to take ACE inhibitors

    go.drugbank.com/conditions/DBCOND0022536
    Drugs: Telmisartan
    Synonyms: Unable to take ACE inhibitors
  5. Drug

    Micafungin

    go.drugbank.com/drugs/DB01141
    ApprovedInvestigational

    It belongs to the antifungal class of compounds known as echinocandins and exerts its effect by inhibiting the synthesis of 1,3-beta-D-glucan, an integral component of the fungal cell wall.

    Products: MYCAMINE 100 MG INFÜZYONLUK ÇÖZELTI IÇIN TOZ, 1 ADET, MYCAMİNE 50 MG IV İNFÜZYONLUK ÇÖZELTİ İÇİN KONSANTRE TOZ
  6. Drug

    Salmeterol

    go.drugbank.com/drugs/DB00938
    ApprovedInvestigational

    [A190477] Salmeterol's structure is similar to salbutamol's with an aralkyloxy-alkyl substitution on the amine.[A183737] Salmeterol was granted FDA approval on 4 February 1994.[L11542]

    Mixtures: PAVTIDE DISKUS 100 MCG INHALASYON ICIN TOZ, 60 DOZ, PAVTIDE DISKUS 250 MCG INHALASYON ICIN TOZ, 60 DOZCategories: Agents to Treat Airway Disease
  7. Drug

    Colistimethate

    go.drugbank.com/drugs/DB01111
    ApprovedInvestigationalVet approved

    Colistimethate is an antibiotic that has been shown to have bactericidal activity against aerobic gram-negative microorganisms. … Colistimethate is particularly indicated when the infection is caused by sensitive strains of Pseudomonas aeruginosa.

    Products: ENJEKSIYON VE INHALASYON IÇIN LIYOFILIZE TOZ IÇEREN FLAKON, 1 ADET, COFİBCOL 4.500.000 IU IM/IV ENJEKSİYONLUK VE İNHALASYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN LİYOFİLİZE TOZ VE ÇÖZÜCÜ, 1 LİYOFİLİZE TOZ İÇEREN FLAKON + 1 ÇÖZÜCÜ İÇEREN AMPUL
  8. Drug

    Belimumab

    go.drugbank.com/drugs/DB08879
    ApprovedInvestigational

    [A251495, L42705] By binding to BLyS and blocking its interaction with B cell receptors, belimumab inhibits the survival of B cells. … [L42630] Belimumab was first approved by the FDA on March 9, 2011,[A251495] making it the newest drug to be approved for the treatment of SLE in more than 50 years.

    Products: BENLYSTA 400 MG IV INFUZYONLUK COZETI HAZIRLAMAK ICIN TOZ ICEREN FLAKON, 1 ADET, BENLYSTA 120 MG IV INFUZYONLUK COZELTI HAZIRLAMAK ICIN TOZ ICEREN FLAKON, 1 ADET
  9. Drug

    5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine

    go.drugbank.com/drugs/DB07140
    Experimental

    Synonyms: 5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine
  10. Drug

    Liothyronine

    go.drugbank.com/drugs/DB00279
    ApprovedInvestigationalVet approved

    Liothyronine is a thyroidal hormone T3 which is normally produced by the thyroid gland in a ratio 4:1 when compared with T4: T3. … [T457] The exogenous liothyronine product was developed by King Pharmaceuticals and FDA approved in 1956.[L5578]

    Categories: Agents used to treat hypothyroidismSynonyms: T3, L-T3